Trillium Therapeutics (TR) News Today Add Compare Share Share Headlines Stock Analysis All Sources Trusted Sources MarketBeat Benzinga Bloomberg GuruFocus MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha TalkMarkets The Street TipRanks The Wall Street Journal Wall Street Zen Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent January 2025 December 2024 November 2024 October 2024 September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 October 2022 September 2022 August 2022 July 2022 June 2022 May 2022 April 2022 March 2022 February 2022 Time Period Targeted Alpha Therapy Market 2028December 12, 2024 | finance.yahoo.comBiomea Announces Formation of Global Scientific Advisory Board with 22 World-Renowned Diabetes ExpertsOctober 1, 2024 | markets.businessinsider.comKabete National Polytechnic Ranked Best TTI in New Timely Kenya SurveyMay 28, 2024 | msn.comPension plans still AWOL as Canadian life-sciences venture capital firms re-up for latest fundsMay 28, 2024 | theglobeandmail.comNimbus Therapeutics Appoints Anita Scheuber, M.D., Ph.D., as Senior Vice President, Therapeutic Area Head, OncologyMay 7, 2024 | finance.yahoo.comRatio Therapeutics Announces the Appointment of Marc Becker as Chief Financial Officer and Chief Operating OfficerMay 6, 2024 | finance.yahoo.comSezary Syndrome Pipeline Insights 2024, Featuring Major Players 4SC, Seagen, Merck Sharp & Dohme, Innate Pharma, Trillium Therapeutics and Secura BioApril 15, 2024 | finance.yahoo.comUpstream Bio Announces Appointment of Rand Sutherland as CEO and Additions to Leadership TeamApril 2, 2024 | finance.yahoo.comRatio Announces Expansion of Manufacturing Agreement with PharmaLogic for FAP-Targeted RadiopharmaceuticalsMarch 12, 2024 | finance.yahoo.comRatio Therapeutics raises $50M for tumor-targeting radiopharmaceuticalsJanuary 17, 2024 | bizjournals.comTvardi Therapeutics Announces First Patients Dosed in its Phase 2 Liver Cancer Trial Using TTI-101, a Novel STAT3 InhibitorJune 22, 2023 | finance.yahoo.comPD-1 Non-Small Cell Lung Cancer Clinical Trials Pipeline Analysis: 20+ Companies are Working to Improve the Treatment Space | DelveInsightJune 20, 2023 | benzinga.comRatio Therapeutics Announces Opening of New Research and Development FacilityMay 9, 2023 | finance.yahoo.comTrillium Engineering Announces Its Latest Innovation in Cameras Utilizing AI Technology - HD80-AIMApril 25, 2023 | finance.yahoo.comWho's Who At The Benzinga Psychedelics Capital Conference? Check Out These CEOs & Meet Them In PersonMarch 10, 2023 | msn.comViridian Therapeutics, Inc: Viridian Appoints Scott Myers as President and Chief Executive OfficerFebruary 6, 2023 | finanznachrichten.deTaylor Trillium building into Division 4 state power, behind coach Terrell GeorgeJanuary 28, 2023 | detroitnews.comLeiomyosarcoma Drug Pipeline Research Report 2022: Comprehensive Insights on 18+ Companies and 18+ Pipeline DrugsDecember 19, 2022 | benzinga.comRatio Therapeutics Appoints Reed Malleck as Chief Financial OfficerDecember 6, 2022 | finance.yahoo.comPfizer: Q3 Earnings Review - Planning For Life After COVIDNovember 3, 2022 | seekingalpha.comCash-rich Pfizer snaps up Global Blood Therapeutics for $5.4 billionAugust 8, 2022 | msn.comPfizer: Management's M&A Activity Is Winning Me OverMay 22, 2022 | seekingalpha.comThiogenesis Therapeutics, Corp.: Thiogenesis Announces Positive Results from Phase 1 Dose-Escalation Study of its Lead Compound TTI-0102May 18, 2022 | finanznachrichten.deThiogenesis Announces Positive Results from Phase 1 Dose-Escalation Study of its Lead Compound TTI-0102May 18, 2022 | stockhouse.com3 Dirt-Cheap Stocks You Can Buy Right NowMay 14, 2022 | msn.comPfizer Buys Biohaven for $11.6BMay 10, 2022 | baystreet.caNeonMind to Open its Inaugural Specialty Mental Health Clinic in Mississauga, OntarioFebruary 17, 2022 | morningstar.com$51,300 OTF Grant helped breast cancer patients in Ontario access educational resources during the pandemicJanuary 25, 2022 | yahoo.comTCR² Therapeutics Announces Experienced Biotech Executive Rosemary Harrison as Chief Business and Strategy OfficerJanuary 12, 2022 | finance.yahoo.comSensorion appoints pharmaceutical industry veteran Scott D. Myers as Chairman of the Board and Independent DirectorDecember 20, 2021 | apnews.comPfizer's $2.3B Trillium Deal Closes Without FTC ChallengeNovember 17, 2021 | law360.comWhy Pfizer Rose While the Market Sank on WednesdayNovember 17, 2021 | nasdaq.comQVT Financial LP Buys S&P 500 ETF TRUST ETF, Trillium Therapeutics Inc, Nelnet Inc, Sells ...November 17, 2021 | gurufocus.comPfizer Completes Acquisition of Trillium TherapeuticsNovember 17, 2021 | finance.yahoo.comPfizer Agrees $2.26 Billion Takeover of Cancer Specialists Trillium TherapeuticsAugust 23, 2021 | msn.comPfizer acquires Trillium Therapeutics at a 200% premiumAugust 23, 2021 | bizjournals.comBRIEF-Pfizer To Acquire Trillium Therapeutics Inc.August 23, 2021 | msn.comPremarket Movers Monday - Pfizer, Trillium, Uber and General MotorsAugust 23, 2021 | msn.comPromising Treatment for Cutaneous T-cell Lymphoma Enters Clinical TrialsAugust 3, 2021 | ca.finance.yahoo.comThis Biotech Stock Is Too Cheap to IgnoreJuly 29, 2021 | nasdaq.comStocks Flat to Begin WeekJuly 26, 2021 | baystreet.caStocks Stable by NoonJuly 26, 2021 | baystreet.ca Get Trillium Therapeutics News Delivered to You Automatically Sign up to receive the latest news and ratings for TR and its competitors with MarketBeat's FREE daily newsletter. Email Address Buy this Stock before Trump Takes Office! (Ad)We're issuing an urgent "buy alert" on a little-known "AI company" set to SOAR under this new administration. And it's not just because it hit a critical "buy now" price. Click here for the ticker >>> TR Media Mentions By Week TR Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. TR News Sentiment▼0.000.78▲Average Manufacturing News Sentiment TR News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. TR Articles This Week▼00▲TR Articles Average Week Get Trillium Therapeutics News Delivered to You Automatically Sign up to receive the latest news and ratings for TR and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies K News KEL News BU News DAR News Headlines Tools Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (TSE:TR) was last updated on 1/4/2025 by MarketBeat.com Staff From Our Partners Is Starlink Set For The Largest IPO In History?He turned PayPal from a tiny, off-the-radar startup… to a massive $64 billion giant. Then, he did it again ...Paradigm Press | SponsoredURGENT: This Altcoin Opportunity Won’t Wait – Act NowCrypto has officially entered the "banana zone" – that wild phase where prices can 1000x in days. It happen...Crypto Swap Profits | SponsoredTSLA *BANG* incoming (bullet in the chamber rn)I just pinpointed 5 dirt-cheap stocks that could soar the second the shot goes off. Thanks to Donald Trump’...StocksToTrade | SponsoredBill Gates’s Next Big AI Bet: StargateIn February 2016… when almost nobody was talking about artificial intelligence…. I picked Nvidia as one of ...Brownstone Research | SponsoredI was wrong. Dead wrong. I thought what happened 25 years ago was a once- in-a-lifetime event… but how wrong I was. Because here we...Porter & Company | SponsoredWARNING: “Buffett Indicator” flashing for first time in 50 yearsWarren Buffett has sold a staggering $97 billion worth of stocks this year... But why? Our research indi...Behind the Markets | SponsoredStunning Trump Exec Order LeakedMost people have no clue this unassuming facility exists. Yet the minute Donald Trump takes office... ...Banyan Hill Publishing | SponsoredThe #1 Crypto for AIWe’ve issued an urgent landmark trade alert for a new crypto wonder. So, I decided to give you this heads-u...Weiss Ratings | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Trillium Therapeutics Inc Please log in to your account or sign up in order to add this asset to your watchlist. Share Trillium Therapeutics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free TR Stock Alerts